Acquired Von Willebrand's Syndrome in Systemic Lupus Erythematosus.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4273461)

Published in Case Rep Hematol on December 07, 2014

Authors

Sara Taveras Alam1, Karenza Alexis2, Ashwin Sridharan3, Marianna Strakhan3, Tarek Elrafei2, Richard J Gralla3, Louis J Reed3

Author Affiliations

1: Department of Internal Medicine, Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY 10461, USA.
2: Department of Hematology and Oncology, Jacobi Medical Center Affiliate of Albert Einstein College of Medicine, 1400 Pelham Parkway, Bronx, NY 10461, USA.
3: Division of Hematology and Oncology, Albert Einstein College of Medicine, Jacobi Medical Center and Montefiore Medical Center, Bronx, NY 10461, USA.

Articles cited by this

Rituximab in the treatment of acquired factor VIII inhibitors. Blood (2002) 1.99

Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study. J Thromb Haemost (2008) 1.80

Acquired von Willebrand disease. Mayo Clin Proc (2002) 1.73

Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost (2000) 1.48

Acquired von Willebrand's syndrome in systemic lupus erythematosus. Blood (1968) 1.40

Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches. Blood (1998) 1.38

How I treat the acquired von Willebrand syndrome. Blood (2011) 1.36

Acquired von Willebrand syndrome: an update. Am J Hematol (2007) 1.13

Rituximab therapy for autoimmune haematological diseases. Eur J Intern Med (2011) 1.11

Four cases of acquired von Willebrand's syndrome. Br J Haematol (1971) 1.06

Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update. Semin Thromb Hemost (2013) 0.99

Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Best Pract Res Clin Haematol (2001) 0.96

Acquired von Willebrand syndrome: is it an extremely rare disorder or do we see only the tip of the iceberg? J Thromb Haemost (2008) 0.92

Acquired von Willebrand syndrome: features and management. Am J Hematol (2006) 0.90

Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications. Semin Thromb Hemost (2006) 0.90

Acquired von Willebrand's syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin. Am J Hematol (1994) 0.90

Diagnosis and treatment of acquired von Willebrand syndrome. Thromb Res (2012) 0.89

Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome. Hum Immunol (2005) 0.88

Dos and don'ts in diagnosing antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program (2012) 0.86

Acquired von Willebrand's syndrome: a single institution experience. Am J Hematol (2003) 0.85

Antibody-induced von Willebrand syndrome: inhibition of VIII VWF and VIII AGN with sparing of VIII AHF by the autoantibody. Am J Hematol (1978) 0.83

Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus. Br J Haematol (1999) 0.82

An atypical manifestation of acquired von Willebrand syndrome (AVWS) associated with systemic lupus erythematosus (SLE). Ann Hematol (2013) 0.81

Autoantibody to von Willebrand factor in systemic lupus erythematosus. J Lab Clin Med (1993) 0.81

Acquired von Willebrand's disease following bone marrow transplantation. Ann Clin Lab Sci (1994) 0.81

Maintaining hemostasis in acquired von Willebrand syndrome: a review of intravenous immunoglobulin and the importance of rituximab dose scheduling. Transfusion (2012) 0.81

Rituximab effectiveness in a patient with juvenile systemic lupus erythematosus complicated with acquired Von Willebrand syndrome. Lupus (2013) 0.81

Acquired von Willebrand's syndrome and systemic lupus erythematosus. Proc R Soc Med (1972) 0.80

Clinical significance of inhibitors in acquired von Willebrand syndrome. Blood (1998) 0.80

Systemic lupus erythematosus complicated by acquired von Willebrand's syndrome. Lupus (2008) 0.79

Diagnosis and management of acquired von Willebrand syndrome. Clin Adv Hematol Oncol (2003) 0.79

Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome. Br J Haematol (2002) 0.79

Advances in hematology. Etiology and diagnosis of acquired von Willebrand syndrome. Clin Adv Hematol Oncol (2010) 0.79

Is rituximab effective in acquired von Willebrand syndrome? Br J Haematol (2008) 0.78

Acquired von Willebrand's syndrome with lupus-like serology. Am J Pediatr Hematol Oncol (1989) 0.78

Acquired von Willebrand syndrome 2004: International Registry--diagnosis and management from online to bedside. Hamostaseologie (2004) 0.78

Acquired von Willebrand's syndrome during autoimmune disorder. Thromb Haemost (1980) 0.77

Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry. Semin Thromb Hemost (2002) 0.77

Development of acquired von Willebrand's disease after mixed connective tissue disease. Am J Med (1988) 0.77

Acquired von Willebrand syndrome: a rare disorder of heterogeneous etiology. J Postgrad Med (2013) 0.77

Puerperal acquired factor VIII inhibitor causing a von Willebrand-like syndrome in a patient with anti-DNA antibodies. Singapore Med J (1995) 0.76

Therapeutic approaches to acquired von Willebrand syndrome. Expert Opin Investig Drugs (2000) 0.76

Acquired type 3-like von Willebrand syndrome preceded full-blown systemic lupus erythematosus. Blood Coagul Fibrinolysis (2002) 0.76

Effectiveness of high-dose intravenous gamma globulin therapy in acquired von Willebrand's disease. Vox Sang (1994) 0.76